Peritoneal mesothelioma (abdomen)
10% to 20% of mesothelioma patients worldwide are affected by peritoneal mesothelioma. This type of mesothelioma has a better prognosis than pleural mesothelioma, despite the fact that less research has been conducted on its tumor cells. According to some studies, almost half of peritoneal mesothelioma patients who undergo heated chemotherapy (HIPEC) and surgery survive for at least five years following a cancer diagnosis. The tumor cells infiltrate the peritoneum lining of the abdomen and effect the mesothelium. This form of mesothelioma is characterized by bowel changes, abdominal pain, abdominal swelling, loss of appetite, and bloating. The prognosis for this form of mesothelioma indicates that approximately 52 percent of patients who undergo surgery with HIPEC survive more than five years.
